Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy

Published:2024-08-12 Issue: Volume: Page:
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Gudera Jonas A.¹²,Baehring Joachim M.¹³,Karschnia Philipp¹²⁴

Affiliation:

1. Department of Neurology, Section for Neuro-Oncology, Yale School of Medicine, New Haven, Connecticut

2. Department of Neurosurgery, Section for Neuro-Oncology, Ludwig-Maximilians-University, Munich, Germany

3. Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut

4. Department of Neurosurgery, Friedrich-Alexander-University, Erlangen-Nuernberg, Germany

Abstract

This case report describes a 67-year-old woman who had received adoptive immunotherapy with chimeric antigen receptor T cells for multiple myeloma and was experiencing parkinsonism-like symptoms.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2822379/jamaneurology_gudera_2024_im_240015_1723127226.62633.pdf

Reference4 articles.

1. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells.;Karschnia;Blood,2023

2. Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy.;Van Oekelen;Nat Med,2021

3. Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity.;Graham;Blood,2023

4. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.;Cohen;Blood Cancer J,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP